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The simultaneous interaction of the binding moieties of
a bidentate ligand on adjacent epitopes of a target pro-
tein represents an attractive avenue for the discovery of
specific, high-affinity binders. We used short DNA frag-
ments in heteroduplex format to scaffold pairs of bind-
ing molecules with defined spatial arrangements. Imi-
nobiotin derivates were coupled either via bifunctional
linkers or by using various oligonucleotides, thus al-
lowing monovalent or bivalent binding to streptavidin.
We determined the binding affinities of the synthesized
constructs in solution. We also investigated the effi-
ciency of recovery of superior bidentate ligands in affin-
ity capture experiments, by using both radioactive
counts and DNA microarrays as readouts. This analysis
confirmed the suitability of the DNA heteroduplex as
a scaffold for the identification of synergistic pairs of
binding moieties, capable of a high-affinity interaction
with protein targets by virtue of the chelate effect.
Introduction
The isolation of molecules capable of high-affinity and
specific binding to a biological target is a central problem
in chemistry, biology, and pharmaceutical sciences. Re-
cent approaches to the solution of this problem include
the generation of large combinatorial libraries [1], the
fragment-based discovery of bidentate ligands to pro-
tein targets [2], as well as the generation of large DNA-en-
coded chemical libraries [3–8]. Heteroduplex DNA struc-
ture may facilitate the self-assembly of pharmacophores
and provide unique oligonucleotide sequences as ‘‘bar-
codes’’ for the identification of preferential binding mol-
ecules [3, 8, 9]. In most cases, high-affinity binders rely
on the simultaneous engagement of adjacent binding
sites of a target protein. However, the contribution of
this chelate binding mode to the overall affinity is largely
unexplored. We used streptavidin and iminobiotin as
a model system by which to investigate to what extent
chelate binding on a target protein by bidentate ligands
contributes to a high-affinity binding interaction.
Results and Discussion
In contrast to biotin, iminobiotin binds to avidin (and less
efficiently to streptavidin) with a moderate affinity con-
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2 These authors contributed equally to this work.stant, in a pH-dependent manner [10]. Streptavidin is a
homotetrameric protein that contains two pairs of adja-
cent binding pockets for iminobiotin (z20 A˚ apart) on op-
posite sides of the homotetramer [11]. We chemically
conjugated either iminobiotin or a cyanine dye (used as
negative control) at the 50 or 30 extremity of amino-mod-
ified oligonucleotides, and we used the resulting conju-
gates in heteroduplex format in binding experiments
with streptavidin (Figure 1A). At the 50 end of the oligonu-
cleotides, we used three linkers of different length that
carry a terminal primary amine (Figure 1B). At the 30
end, we used three structurally different linkers (Fig-
ure 1B), which resulted in different exit vectors for phar-
macophores attached to amino-tagged oligonucleotide
heteroduplexes (Figures 1C and 1D). In particular, the
use of linker z, in which the iminobiotin emerges from
an additional 30 terminal base moiety, allowed for the pre-
paration of DNA fragments in which the exit vectors for
the attached chemical moieties are essentially parallel.
We used band-shift experiments [12, 13] to determine
the dissociation constant (Kd) in solution for complexes
between oligonucleotide derivatives in a stable hetero-
duplex format (24 bases) and streptavidin as target pro-
tein. In these experiments, a complex is allowed to form
in solution; once equilibrium is reached, the unbound
DNA fragment and the DNA-protein complex are sepa-
rated by native gel electrophoresis. The relative ratios
of bound and unbound DNA fragments allow for the de-
termination of an apparent Kd value.
The spatial arrangements of iminobiotin moieties, re-
sulting from the combination of different iminobiotin-
DNA linker structures, contributed to different binding
affinities to streptavidin. While no complex formation be-
tween monodentate iminobiotin-DNA derivatives was
observed at concentrations as high as 100 mM, stable
complexes with streptavidin could be observed for all bi-
dentate iminobiotin derivatives (Figure 2). The highest
binding affinity originated from the combination of linker
z at the 30 end, and linkers b or c at the 50 end, with an ap-
parent dissociation constant to streptavidin of 140 nM,
indicating an apparent affinity gain mediated by the che-
late effect of at least a factor of 700. Hamblett and col-
leagues [14] had previously reported a 640-fold gain in ki-
netic stability of bidentate biotin derivatives to the Y43A
streptavidin mutant, which displays a modest binding
affinity to biotin and monovalent biotin derivatives.
The self-assembly of DNA oligonucleotides carrying
individual chemical compounds at their extremities en-
ables the facile generation of large chemical libraries
from smaller sublibraries [8, 15]. The isolation of binding
molecules to target proteins of choice from such self-as-
sembled heteroduplex libraries or from other DNA-en-
coded libraries [3–7] entirely relies on the specific en-
richment of binding compounds from the library
compounds, with a clear correlation between enrich-
ment and binding affinity.
The band-shift experiments shown in Figure 2 clearly
indicate that the linker structures used to connect bind-
ing moieties and the DNA heteroduplex greatly influence
the resulting binding affinity of bidentate ligands for the
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226Figure 1. Bidentate Ligands Scaffolded by Heteroduplex DNA
(A) Schematic representation of a bidentate iminobiotin ligand simultaneously interacting with adjacent iminobiotin binding sites of a strepta-
vidin tetramer and of monodentate binding. Dimerization is mediated by double-strand formation of DNA oligonucleotides that are covalently
coupled to iminobiotin or a cyanine dye (used as negative control) on their 50 or 30 termini, respectively.
(B) Structure of different primary amino modification linkers of DNA oligonucleotides. a, b, c: 50-amino modifications with different linkers orig-
inating from the 50 phosphate group of the 50 terminal deoxyguanosine nucleotide, R1: 50-gagcttctgaattctgtgtgctg-30. x, y: 30-amino modifica-
tions with linkers originating from the 30 phosphate group of the 30 terminal deoxycytidine, R2: 50-cagcacacagaattcagaagctc-30. z: 30 amino
modification originating from additional base at the 30 terminus.
(C and D) Three-dimensional models of the extremities of a DNA segment (B-form) from which linkers to organic molecules originate (‘‘exit
vectors’’). (C) 50-amino-modified oligonucleotide (formats a, b, c) paired with a 30-amino-modified oligonucleotide (formats x, y). (D) 50-
amino-modified oligonucleotide (formats a, b, c) paired with a 30-amino-modified oligonucleotide (format z).corresponding protein target (Figure 1). Since affinity se-
lection methodologies crucially rely on the preferential
recovery of higher-affinity binders, we studied how the
improved affinity of bidentate ligands influences their re-
covery. For this reason, we performed panning experi-
ments with streptavidin and (mono- or bidentate) imino-
biotin derivatives, and we quantified the enrichment
factors in the selections either by radioactive counting
or by using DNA microarrays.33P-labeled oligonucleotide derivatives carrying imi-
nobiotin and/or cyanine dyes as chemical moieties at
their extremities were allowed to form a double-
stranded DNA structure and were incubated with strep-
tavidin-sepharose beads. After repeated rounds of
washing, aliquots of the input, of the flowthrough, of
the wash fractions, and of the oligonucleotides recov-
ered after selections were subjected to radioactivity
counting. For comparison, an excess of free iminobiotin
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227Figure 2. Affinity Determination by Band-Shift Experiments
Affinity determination by band-shift experiments of oligonucleotides conjugated with iminobiotin to tetrameric streptavidin. Gel images were
recorded by fluorescence imaging utilizing Cy3-labeled oligonucleotides. Bidentate iminobiotin ligands (as in Figure 1A) in all possible com-
binations between 50 iminobiotin (linker structures a, b, and c) and 30 iminobiotin (linker structures x, y, and z) were assayed. Monodentate 50
iminobiotin with linker structures a, b, and c, as well as monodentate iminobiotin with linker structures x, y, and z, was assayed (paired with
a Cy3-labeled oligonucleotide). All bidentate iminobiotin derivates show a higher affinity to streptavidin in the band-shift assay compared with
the monodentate derivates.was added to the samples after incubation of the dou-
ble-strand oligonucleotides with streptavidin sepharose
in order to increase the stringency of selection, favoring
ligands with higher kinetic stability.
Figure 3 shows that bidentate iminobiotin derivatives
are preferentially enriched (63.2% recovery) in affinity
selections, compared to monodentate iminobiotin li-
gands (17.1% and 21.1% recovery) and to irrelevant
chemical moieties (0.21% recovery). Increasing the
stringency of the selection by adding 1 mM free imino-
biotin did not substantially lower the recovery of the bi-
dentate ligand (16.9% recovery), while the recovery of
monodentate ligands (1.1% and 1.8%) was reduced al-
most to background levels (0.22%).
In affinity selections, based on encoded self-assem-
bling chemical libraries [8], the identification of higher-
affinity binders from a library of compounds typically re-
lies on the use of oligonucleotide microarrays, which
display stronger fluorescence signals for those com-
pounds that are preferentially enriched. In order to study
whether the capture of iminobiotin ligands from a library
of compounds can be detected on oligonucleotide mi-
croarrays, we paired one oligonucleotide (carrying the
iminobiotin moiety) with a library of 138 oligonucleotide
derivatives, carrying different chemical groups (one of
them being iminobiotin, with code number 76). Addition-
ally, we studied the selection of one oligonucleotide
(carrying a cyanine dye as a chemical group with no de-
tectable binding affinity for streptavidin), paired with the
library of 138 compounds.
Both libraries were subjected to affinity selection ex-
periments by using streptavidin immobilized on sephar-
ose beads, either in the presence or in the absence of
free iminobiotin as competitor. After several rounds of
washing, the beads were used as a template for a mod-ified polymerase chain reaction (PCR) amplifying the co-
des of the preferentially enriched library compounds.
The fluorescence signals on the microarray, corre-
sponding to the hybridization with the PCR product, re-
vealed a preferential enrichment of the bidentate imino-
biotin derivative (over the monodentate iminobiotin
derivatives) in the first selection (Figure 4A), and of the
monodentate iminobiotin derivative 76 in the second se-
lection (Figure 4B).
For most practical applications, synergistic binding
pairs coupled together by bifunctional chemical cross-
linkers are more suitable than those scaffolded by het-
eroduplex DNA. Based on the results of the band-shift
experiments with different pairs of iminobiotin-oligonu-
cleotide conjugates, we selected Cy5, in which the exit
vectors are similar both in distance and direction to
those in the DNA heteroduplex, as a chemical scaffold
(Figures 5A and 5B). We synthesized a bis-iminobiotin
derivative of Cy5 with flexible linkers, and we deter-
mined its affinity to streptavidin by isothermal titration
calorimetry. The bis-iminobiotin conjugate has a dissoci-
ation constant, Kd, of 6 nM to streptavidin, which corre-
sponds to a >2000-fold affinity increase when compared
to free iminobiotin, which displays a Kd of 13 mM (Figures
5C and 5D). The corresponding mono-iminobiotin con-
jugate did not display any binding under conditions sim-
ilar to those for the bis-iminobiotin conjugate.
Significance
The results of this study have taught us valuable les-
sons for affinity selection experiments. First, bidentate
ligands engaging adjacent epitopes on a target protein
enjoy a strong affinity gain due to the chelate effect.
Second, DNA appears to be an excellent scaffold for
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228Figure 3. Recovery of Ligands in Affinity Selection Experiments
(A and B) Recovery profiles of bidentate and monodentate iminobiotin ligands, as well as of negative control ligands, in affinity selection ex-
periments to streptavidin, as determined by using radiolabeled oligonucleotides. Aliquots of the different stages of the selection procedure
were collected, subjected to radioactivity measurements, and normalized to the input value. The curves were drawn by plotting the fraction
of radioactivity present in the eluate (last data point on the x axis), and by adding up the fractions of radioactivity measured in the different
washing steps in the selection procedure. In order to alter the stringency of the affinity selection, the experiment was performed (A) without
competition or (B) in the presence of 1 mM free iminobiotin as competitor.synergistic binding moieties, but the choice of suitable
exit vectors for the functional groups strongly influ-
ences the binding affinity. Third, high-affinity biden-
tate ligands are captured preferentially and with excel-
lent recoveries, and these selections can be monitored
not only with radioactive counting, but also with oligo-
nucleotide microarrays, thus allowing the identifica-
tion of preferred binders. Adjusting the stringency in
the washing steps of the selection influences the rela-
tive recovery of ligands with different affinity for the
targets. Fourth, it is possible to convert the selectedpharmacophores to high-affinity bivalent binders by
selecting suitable chemical scaffolds.
The combination of affinity selections [16, 17] and
DNA encoding of chemical compounds [3–9] is facili-
tating the isolation of small organic molecules capable
of specific protein recognition. Fragment-based iden-
tification of bidentate ligands [2] is a promising ave-
nue for the development of general methods for dis-
rupting protein-protein interactions, one of the big
open challenges in medicinal chemistry and chemical
biology.
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Abbreviations
Abbreviations used in this paper are as follows: iminobiotin, 5-(7-
amino-3-thia-6,8-diazabicyclo[3.3.0]oct-6-en-4-yl)pentanoic acid;
NHS, N-hydroxysuccinimido ester derivative; TEA, Triethylamine.
Figure 4. Readout of Selection Results by Microarray Technology
(A and B) Microarray decoding of test selection experiments
against streptavidin by using a 138-compound library paired with
an oligonucleotide covalently conjugated to (A) iminobiotin or (B)
an irrelevant organic molecule (Cy3). The three microarray panels
represent the microarray signals before selection, after selection
without competition, and after selection with competition with 1
mM free iminobiotin. The five spots representing the signal for
compound 76 (iminobiotin) are magnified, while the signals of pos-
itive control oligonucleotides are highlighted by red boxes. The
graphs represent ratios of the average signal intensities for individ-
ual compounds after and before selection.Materials
Amino-modified and fluorescently labeled oligonucleotides were
purchased from IBA (Go¨ttingen, Germany). Oligonucleotide microar-
rays and the 137 compound library were produced as described [8].
Chemicals were purchased from Sigma-Aldrich-Fluka (Buchs, Swit-
zerland), unless otherwise stated. The oligonucleotides used in
band-shift assays have the following sequences (the hybridization
sequences are underlined). Sequence of 50 iminobiotin-modified
oligonucleotides (with linker structures a, b, or c; Figure 1B): imino-
biotin-(linker a/b/c)-50-GGAGCTTCTGAATTCTGTGTGCTGGATAA
ACGACACGAATTCCGCAGC-(Cy3)-30; sequence of 30 iminobiotin-
modified oligonucleotides (with linker structures x, y, or z; Figure 1B):
50-CAGCACACAGAATTCAGAAGCTCC-30-(linker x/y/z)-iminobiotin.
For monodentate iminobiotin derivates, B30(Cy3) (50-CAGCACACA
GAATTCAGAAGCTCC-30-(z)-Cy3) or B50(Cy3) (Cy3-(b)-50-GGAGCT
TCTGAATTCTGTGTGCTG-30) were used as dummy pairing oligonu-
cleotides. For quantitative model selection experiments, the follow-







Chemical Conjugation of Iminobiotin to Oligonucleotides
Compounds were added to 120 ml of a 40% DMSO solution, reaching
the following final concentrations: iminobiotin-NHS, 1.6 mM; amino-
modified oligonucleotide, 85 mM; TEA/HCl buffer (pH 10), 400 mM.
The coupling reactions were stirred overnight at room temperature,
and residual activated species were then quenched by the addition
of 50 ml 1 M Tris-Cl buffer (pH 8.0). The reaction was purified by HPLC
on a XTerraRP C18(2) column (Waters, Milford, MA) by using a linear
gradient from 100 mM triethylammonium acetate (TEAA) (pH 7.0) to
100 mM TEAA containing 80% (v/v) acetonitrile (pH 7.0). Solvents
and volatile salt were removed under vacuum. The dried oligonucle-
otides were resuspended in 1 ml 20 mM TEA/HCl (pH 10) and were
loaded on 0.5 ml avidin sepharose resin slurry (Affiland, Ans-Liege,
Belgium). After washing the resin twice with 2 ml 20 mM TEA/HCl
(pH 10), the iminobiotin oligonucleotides were eluted with 0.1%
TFA (pH 2). After neutralizing the pH by addition of 1 M NaHCO3,
the iminobiotin oligonucleotide conjugates were again dried under
vacuum.
Band-Shift Assays
The oligonucleotides carrying an iminobiotin moiety at the 50 end
were Cy3 labeled at the 30 end, thus allowing for oligonucleotide de-
tection on gels. Combinations of oligonucleotides were mixed in
equimolar ratio with 150 mM Tris-HCl, 10 mM MgCl2 (pH 8.9) as
buffer, and they were incubated for 3 min at 94ºC and for 10 min at
50ºC to promote hybridization. Band-shift assays were performed
by incubating the mono- and bidentate iminibiotin derivatives with
various concentrations of streptavidin in 150 mM Tris-HCl, 10 mM
MgCl2 (pH 8.9) for 1 hr prior to loading onto a 15% native PAGE
gel [18]. The final concentration of double-stranded oligonucleotide
in the 10 ml of sample loaded on the gel was 6.6 nM. The final mono-
meric streptavidin concentrations were as follows: 103 mM, 34 mM,
11 mM, 3.8 mM, 1.3 mM, 420 nM, 140 nM, 47 nM, and 0 nM. The
gels were run for 2 hr at 100 V. Detection was performed with a Diana
III imager, using Cy3-filters (Raytest, Germany). The cage effect, i.e.,
the improved kinetic stability of complexes within the native poly-
acrylamide gel matrix, extends the scope of band-shift experiments
for complexes with dissociation constants ranging from picomolar
to micromolar values [12, 13].
Quantitative Model Selection Experiments
Oligonucleotides IMI(30) and Cy5(30) were radioactively labeled at
their 50 termini by using g33P-ATP (Amersham) and T4 polynucleo-
tide kinase (USB). In four separate tubes, the four possible pairs of
oligonucleotides were mixed at 45 nM concentration, and hybridiza-
tion was allowed to occur as described above. To this solution, 50 ml
streptavidin-sepharose slurry (GE Healthcare), which had previously
been preblocked in 1 mg/ml herring sperm DNA, was added. After
30 min of incubation, free iminobiotin was added to an end
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230Figure 5. Bis-Iminobiotin Cy5 Conjugate Displays High Affinity to Streptavidin
(A) Three-dimensional model of the terminal bases and their exit vectors (arrows) of the DNA heteroduplex combination corresponding to the
entities with the highest affinities to streptavidin in the band-shift experiment.
(B) Three-dimensional model of Cy5. The exit vectors are similar both in distance and direction to those in the DNA heteroduplex.
(C and D) Isothermal titration calorimetry profiles of the binding reaction of (C) free iminobiotin and (D) bis-iminobiotin to streptavidin reveal
dissociation constants, Kd, of 13 mM and 6 nM, respectively.concentration of 1 mM and was incubated for 5 min only in the com-
petition experiments. After repeated rounds of washing, the remain-
ing beads as well as aliquots of the input, flowthrough, and all wash-
ing fractions were subjected to 33P radioactivity counting with
a Beckman LS 6500 scintillation counter.
Test Selections with Library and Microarray Readout
Oligonucleotide with the code number 76 was coupled to iminobio-
tin as described above and were added to the previously described
library of 137 compounds [8]. The resulting 138 compound library
was paired with either oligonucleotide IMI(30) or Cy3(30). Selections
with the resulting double-stranded libraries were performed with
streptavidin-sepharose slurry as described above. For decoding, al-
iquots of the library before selection, and the samples after selec-
tion, were used as templates in a two-step PCR reaction (first
step: 25 cycles of 1 min at 94ºC; 1 min at 55ºC; 20 s at 72ºC). In the
first step, primers ABfo_short (50-GGAGCTTCTGAATTCTGTGT-30;
400 nM) and Aba (50-GCTGCGGAATTCGTGTCG-30; 400 nM; IBA)
were used; however, in the second step, only the Cy3-labeled primer
Aba (400 nM; IBA) was used. Additionally, in the second step, puri-
fied PCR products of the first step of the PCR reaction were used
as templates (22 cycles of 1 min at 94ºC; 1 min at 55ºC; 20 s at
72ºC), yielding an excess of Cy3-labeled single-stranded target
DNA. The reaction product was extracted with phenol/chloroform
by using Phase Lock Gel tubes (Eppendorf, Hamburg, Germany)
and was precipitated in ethanol. The DNA pellet was resuspended
in 100 ml hybridization buffer (43 SSC, 50 mM HEPES, 0.2% [w/v]
SDS [pH 7]) and was incubated with the microarrays in a Tecan
HS4800 hybridization instrument (Tecan, Ma¨nnedorf, Switzerland)
for 4 hr at 44ºC; this was followed by successive washing steps
with 23 SSC/0.2% (w/v) SDS, 0.23 SSC/0.2% (w/v) SDS, and 0.23
SSC for 90 s. After hybridization, microarrays were analyzed with
a Scan Array 5000 instrument (Perkin Elmer; ex = 543 nm; 70% laserpower; gain of photomultiplier = 90%). Spot intensities were quanti-
fied with GeneSpotter image analysis software (MicroDiscovery).
The local background was substracted from the mean value of
each spot, and the average of five spot values gave the signal value
for each compound.
Synthesis of Cy5 Derivatives
1,8-diamino-3,6-dioxaoctane (400 mmol) and triethylamine (1 mmol)
were mixed with 210 ml DMSO. Cy5 bis NHS ester (400 nmol, GE
Healthcare) dissolved in 100 ml DMSO was added and stirred at
30ºC. After 12 hr, tris(hydroxymethyl)aminomethane (10 mmol) in
100 ml H2O was added to quench unreacted NHS ester. The reaction
mixture was purified on a Synergi 4u POLAR-RP column (Phenom-
enex, Torrance, CA) with a linear gradient from 0.1% TFA in H2O to
100% acetonitrile. The fractions containing the mono- and bis-1,8-
diamino-3,6-dioxaoctane-Cy5 derivatives were collected, and the
solvent was removed. The Cy5 derivatives (w50 nmol) were redis-
solved in DMSO. Triethylamine (7.2 mmol) and iminobiotin NHS ester
(1 mmol) dissolved in 100 ml DMSO were added. The reaction was
stirred at 30ºC. After 12 hr, tris(hydroxymethyl)aminomethane (10
mmol) in 100 ml H2O was added to quench unreacted NHS ester.
The reaction mixture was purified on a Synergi 4u POLAR-RP col-
umn (Phenomenex, Torrance, CA) with a linear gradient from 0.1%
TFA in H2O to 100% acetonitrile. The fractions containing the
mono- and bis-iminobiotin-1,8-diamino-3,6-dioxaoctane-Cy5 deriv-
atives were collected, and the solvent was removed. The molecules
were characterized by mass spectrometry.
Isothermal Titration Calorimetry
Isothermal titration calorimetry measurements were performed with
a VP-ITC instrument (Microcal, Northampton, MA). 100 mM strepta-
vidin was titrated with a 1 mM solution of iminobiotin. 1 mM Cy5 de-
rivative was titrated with a 10 mM solution of streptavidin (after an
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231initial dummy injection of 1 ml, 29 injections of 10 ml each were per-
formed). All solutions were 25 mM NaHCO3, 150 mM NaCl, 5%
DMSO (pH 11.1), and the experiments were performed at 30ºC.
The resulting titration curves were then processed and fitted with
the Origin 7 software.
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